BAC vs PFE: Which Is the Better Buy?
Side-by-side comparison of Bank of America Corporation and Pfizer Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-11.
Bank of America Corporation · Financial Services
$52.54
+7.3% upside to fair value
Grade B+
VS
Pfizer Inc. · Healthcare
$26.91
+30.1% upside to fair value
Med Conviction
Grade B+
QuantHub Verdict
PFE has more upside to fair value
(+30.1%).
PFE trades at a lower forward P/E
(9.5x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
BAC |
PFE |
| Current Price |
$52.54 |
$26.91 |
| Fair Value Estimate |
$56.39 |
$35.00 |
| Upside to Fair Value |
+7.3%
|
+30.1%
|
| Market Cap |
$377.1B |
$153.0B |
| Forward P/E |
12.1x
|
9.5x
|
| EV / EBITDA |
12.8x
|
13.8x
|
| Price / Sales |
2.0x
|
2.4x
|
| Price / FCF |
29.9x
|
16.8x
|
| Revenue Growth YoY |
-0.5%
|
-1.6%
|
| Gross Margin |
56.1%
|
70.3%
|
| Operating Margin |
19.7%
|
24.7%
|
| Return on Equity |
10.1%
|
9.0%
|
| Dividend Yield |
2.09% |
6.4% |
| FCF Yield |
3.35%
|
5.9%
|
| Analyst Consensus |
Buy
|
Hold
|
Investment Thesis
Bank of America is a top-two U.S. bank by assets with $3.4 trillion on its balance sheet, generating $30.5 billion in net income in 2025 on the back of 12.5% earnings growth. The bank benefits from scale in consumer deposits, a recovering investment banking franchise, and an expanding digital platform serving 47 million active users. At 12.7x trailing earnings and 1.97x sales, BAC trades at a fai…
Pfizer remains the world's largest traditional pharmaceutical company by non-COVID revenue, generating $62.6B in 2025 sales across oncology, cardiovascular, immunology, and vaccines. The stock trades at a P/S of 2.44x, still well below the 5-year median of 3.10x, driven by post-COVID revenue normalization, a $17-18B patent cliff spanning 2026-2028, and $61.6B in acquisition-related debt from Seag…
Accumulation Zones
| Metric |
BAC |
PFE |
| Zone Low |
$42.29 |
$25.00 |
| Zone High |
$47.93 |
$29.00 |
| In Buy Zone? |
No
|
Yes
|